ROCHE HOLDING AG All trademarks used or mentioned in this release are protected by law. Roche Group Media Relations Phone: +41 61 688 8888 / e-mail: media.relations@roche.com https://www.globenewswire.com/Tracker?data=dsBnhF2iGRorYbR4tIcC2tqe0Kz3wBJ6LcQtYXnNnpFaEHHTfzJykqU4o5tyV0Hh6P6ajaUTWs1YANKOL_albg5w-shPiOkraUvArZpNYklW7CNBjU65Av8RZ_UEZKYC Dr. Nicolas Dunant Patrick Barth Phone: +41 61 687 05 17 Phone: +41 61 688 44 86 Dr. Daniel Grotzky Karsten Kleine Phone: +41 61 688 31 10 Phone: +41 61 682 28 31 Nina Mählitz Nathalie Meetz Phone: +41 79 327 54 74 Phone: +41 61 687 43 05 Dr. Barbara von Schnurbein Phone: +41 61 687 89 67 Roche Investor Relations Dr. Karl Mahler Jon Kaspar Bayard Phone: +41 61 68-78503 Phone: +41 61 68-83894 e-mail: karl.mahler@roche.com e-mail: jon_kaspar.bayard@roche.com Dr. Sabine Borngräber Dr. Bruno Eschli Phone: +41 61 68-88027 Phone: +41 61 68-75284 e-mail: sabine.borngraeber@roche.com e-mail: bruno.eschli@roche.com Dr. Birgit Masjost Dr. Gerard Tobin Phone: +41 61 68-84814 Phone: +41 61 68-72942 e-mail: birgit.masjost@roche.com e-mail: gerard.tobin@roche.com Investor Relations North America Loren Kalm Dr. Lisa Tuomi Phone: +1 650 225 3217 Phone: +1 650 467 8737 e-mail: kalm.loren@gene.com e-mail: tuomi.lisa@gene.com Attachment -- 23042021_MR_ENSPRYNG https://ml-eu.globenewswire.com/Resource/Download/e196a165-2e55-43be-adcf-cb16425dcdb7
(END) Dow Jones Newswires
April 23, 2021 07:00 ET (11:00 GMT)
